In the Evidence Based Review article entitled "Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary Syndromes. Can We Expect a MIRACL from Cholesterol Lowering Therapy?" published in The Journal of Informed Pharmacotherapy 2001;7:204-207, an error occurred on page 205. Under the section "How large was the treatment effect?", the first sentence should read "During the 16-week follow-up period, a primary end point occurred in 14.8% of the atorvastatin group and 17.4% of the placebo group (p=0.048), ARR = 2.6% (95% CI 0% to 5.2%), NNT = 38 (95% CI 20 to 11,893)."
View the Evidence Based Review Article
Copyright © 2001 by the Journal of Informed Pharmacotherapy. All rights reserved.